AI-Designed Antibiotics Combat Superbugs and Drug-Resistant Bacteria

AI has designed two new potential antibiotics targeting drug-resistant gonorrhoea and MRSA, showing promise in laboratory and animal tests, but they still require years of refinement and clinical trials before potential use in humans. The research highlights AI's role in revolutionizing antibiotic discovery amidst rising antibiotic resistance, though challenges remain in drug manufacturing and economic viability.